Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Progressive Leukodystrophy-Like Demyelinating Syndromes with MOG-Antibodies in Children: A Rare Under-Recognized Phenotype.

Neuropediatrics - 1 Aug 2021

Yazbeck Elise, Maurey Hélène, Leroy Carole, Horellou Philippe, Napuri Silvia, Lali Mohammed, Adam Clovis, Husson Beatrice, Sevin Caroline, Deiva Kumaran

Abstract excerpt

Acquired demyelinating syndromes (ADS) are frequently associated with myelin oligodendrocytes glycoprotein (MOG) antibodies in children. Clinical phenotypes are heterogeneous and may delay the diagnosis, especially when they relapse and are atypical, mimicking diseases such as multiple sclerosis or neuromyelitis optica spectrum disorders . Here, we describe two children: one with a progressive cognitive and...

Topics

Autoantibodies
Humans
Myelin-Oligodendrocyte Glycoprotein
Neuromyelitis Optica
Phenotype
Retrospective Studies
Syndrome

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33792000
DOI: 10.1055/s-0041-1726289

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Progressive Leukodystrophy-Like Demyelinating Syndromes with MOG-Antibodies in Children: A Rare Under-Recognized Phenotype.PMID 33792000Read ↗

'Leukodystrophy-like' phenotype in children with myelin oligodendrocyte glycoprotein antibody-associated disease.Semantic proximity Read ↗

E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.Semantic proximity Read ↗

Less common phenotypes of myelin oligodendrocyte glycoprotein antibody-related diseases in children deserve more attention.Semantic proximity Read ↗

Attack phenotypes and disease course in pediatric MOGAD.Semantic proximity Read ↗

Clinical features of the first attack with leukodystrophy-like phenotype in children with myelin oligodendrocyte glycoprotein antibody-associated disorders.Semantic proximity Read ↗

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Pathophysiology, Clinical Patterns, and Therapeutic Challenges of Intractable and Severe FormsSemantic proximity Read ↗

Myelin Oligodendrocyte Glycoprotein–Associated DisordersSemantic proximity Read ↗

MOGAD update: new phenotypes in the expanding clinical spectrum.Semantic proximity Read ↗

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Insights into pathogenesis and biomarkers of prognosisSemantic proximity Read ↗

Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating DiseasesSemantic proximity Read ↗

E.U. paediatric MOG consortium consensus: Part 4 - Outcome of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.Semantic proximity Read ↗

Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.